ArticleNational journal of maxillofacial surgery
Comparative efficacy of photodynamic therapy versus triamcinolone in symptomatic oral lichen planus: IL-1Beta, IL-6, TNF-Alpha, and MDA biomarker analysis.
Article in National journal of maxillofacial surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Photodynamic therapy for oral mucosal lesions: photosensitizer evolution, pharmacological mechanisms, and clinical translation.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Oral lichen planus (OLP) is a chronic inflammatory, autoimmune, and potentially malignant disorder of the oral mucosa. Photobiomodulation (PBM) aids tissue repair, while photodynamic therapy (PDT) selectively targets diseased cells and modulates cytokines. This study compares the effectiveness of PDT (660 nm) and triamcinolone acetonide 0.1% in managing symptomatic OLP. It evaluates their impact on serum and salivary biomarkers (IL-1Beta, IL-6, TNF-alpha, and MDA) at baseline and at 3 months and correlates these markers with pain and clinical scores (VAS and RAE) to determine their therapeutic efficacy. Materials and Methods: A randomized controlled trial on 28 OLP patients compared two treatments: Group I received 0.1% TA (3 times/day for 1 month); Group II underwent PDT with 1% toluidine blue and 660 nm diode laser (100 mW, 60 sec/cm², 2 times/week for 1 month). Pain with VAS and lesion size with RAE were assessed at baseline and 1, 2, and 3 months. Biomarkers were evaluated using ELISA and thiobarbituric acid tests. Results: Both treatments significantly reduced pain and lesion size. PDT demonstrated greater pain reduction than TA and slightly more lesion size reduction, though not statistically significant. Biomarkers showed no significant changes except a correlation between salivary IL-1β and VAS in the TA group. Conclusion: PDT and TA effectively managed pain and lesion size in OLP, with PDT showing a trend toward greater improvement. PDT is a promising alternative for OLP management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.